Zantac Class Action Lawsuit
What is Zantac?
Otherwise known as it’s generic name Ranitidine, Zantac reduces the production of stomach acid. Zantac is used to treat and prevents stomach and intestinal ulcers. It is also effective in treating symptoms brought on by gastroesophageal reflux disease (GERD), peptic ulcer disease, heartburn, and acid indigestion. Zantac can be obtained by both prescription and over the counter from 20 manufacturers.
Zantac or Ranitidine are part of a class of drugs known as histamine-2 (h2) blockers. The over the counter version of Zantac is primarily used for heartburn relief, while the prescribed version is used to prevent ulcers an other serious medical conditions.
FDA Warnings Zantac & NDMA
The FDA has warned consumers of a carcinogen that has been found in Zantac. Studies are showing NDMA in Zantac and Ranitidine medications are at levels ranging in the thousands of times higher than standards approved by the FDA. Current civil suits are alleging the pharmaceutical companies that manufacture and sell Zantac and Ranitidine designed and manufactured the drug in a defective manner, knew of the risks, and failed to alert consumers through warning labels and other means. If Zantac users were made aware that the drug they were ingesting would cause cancer, they would not have taken it.
Exposure to NDMA Causes Symptoms like:
- Abdominal cramps
NDMA Exposure Can Cause Various Forms of Cancer and Medical Problems such as:
- Bladder Cancer
- Breast Cancer
- Colorectal Cancer
- Intestinal Cancer
- Esophageal Cancer
- Gastric Cancer
- Kidney Cancer
- Liver Cancer
- Lung Cancer (for non-smokers)
- Pancreatic Cancer
- Prostate Cancer
Retailers puled Zantac off their shelves immediately following the release of a study that showed dangerous levels of NDMA in Zantac. However, the FDA did not issue a recall immediately which lead to manufacturers to continue producing the drug, and some companies continued to sell it.
Further investigation and studies led the FDA to order all manufactures to remove prescription and over the counter Ranitidine drugs from the market completely April 1, 2020. An advisement to consumers was also issued to stop taking the over the counter Zantac and Ranitidine, dispose their medications properly, and forgo buying more. Patients that were prescribed Ranitidine were encouraged to speak with their physician about alternative methods for treatment, including multiple drugs that were approved by the FDA that did not carry the risks from NDMA such as Pepcid, Tagamet, Nexium or Prilosec.
Holding the Drug Companies Responsible
If you have elected to pursue a financial award through a lawsuit against the manufacturer of Zantac, there is a strict deadline you must follow. Each state carries a different statute of limitations for defective drugs. Typically the limitations are between one and five years. These limitations explain how long after your cancer diagnosis you have a right to sue for damages. If you do not bring a lawsuit prior to the expiration of the statute of limitations, you lose your right to pursue compensation.
Compensation Available in a Lawsuit
Choosing to file a lawsuit against the markets of Zantac could potentially create a situation where you’re entitled to financial compensation for both past and future damages. Compensatory damages are in reference to the expenses and suffering as a result of someone else’s negligence. These damages fall under two categories: economic and non-economic. You could pursue damages that include past and future medical expenses, loss of income and lost future earnings, physical pain, emotional distress, physical impairment or disability, the loss of enjoyment of life, and loss of companionship or consortium.
Join the Zantac Class Action Lawsuit Today!
If you feel you have a case and would like to join the Zantac Class Action Lawsuit, click below to get in touch with one of our attorneys today!